From Towa
to the World
Our Journey begins in 1951
Towa Pharmaceutical was founded in Osaka, Japan as a wholesale and brokerage of pharmaceutical raw materials.
Towa Group contributes to people’s health by creating superior products and services.
Through our corporate activities, we aim to be a company that is valued and needed by patients, medical professionals, local communities, and others.
In 2020 Towa became international by adding the Pensa Pharma business, a well-established patent medicine platform with a commercial presence in the US and the EU and R&D and manufacturing capabilities.
Through this internationalization milestone, Towa International headquarters were established in Barcelona, Spain.
At Towa International, we work to research, develop and market generic and value-added medicines (VAM) that contribute to improving the health of patients. In turn, they allow greater availability and better management of treatments for health professionals and support the sustainability of health systems in more than 30 countries in which we operate.
#FromTowaToTheWorld
Our story together
TOWA
PHARMACEUTICAL
TOWA
INTERNATIONAL
1951
Towa Pharmaceutical was founded.
1989
Pensa originates from PPI expertise and a non-infringement formulation of Omeprazole
1992
Contruction of Martorelles (Barcelona) manufacturing and R&D facilities
1996
Mr. Itsuro Yoshida became the president
1998
Creation of B2B business
1998
Osaka Research Center and Osaka Distribution Center are constructed at Ichiban-cho, Kadoma, Osaka
1999
Launch of Omeprazole
2004
Towa was listed on stock exchange
2006
Pensa Pharma Foundation
2007
Start of the internationalisation phase. Expanded Pensa into Italy with the purchase of 20 additional products.
2008
Built pilot plant and expanded R&D capabilities. Entered Portugal through the acquisition of toLife, adding 30 additional products to Pensa’s portfolio
2009
Entered U.S.A with acquisition of Breckenridge. Entered Sweeden
2010
Towa purchases Daichi Kasei Co., Ltd., and makes it subsidiary
2012
Entered Germany
2016
Established Greencaps Pharmaceutical Co., Ltd.
2020
Foundation of Towa Pharma International Holding
2020
Internationalisation
2021
Expansion manufacturing facilities
2021
Towa purchases Protosera Inc. and makes it subsidiary
2022
Internalization process. Entering South America and Middle East though licenses
2022
Towa purchases Sunsho Pharmaceutical Co., Ltd. and makes it subsidiary